RecruitingNot ApplicableNCT05584449

Group Curriculum for Improving Survivorship Outcomes in Adolescent and Young Adult Cancer Survivors

Determining the Impact of a Curriculum for a Cancer Survivorship Group for Adolescents and Young Adults (AYA)

Sponsor

Mayo Clinic

Enrollment

60 participants

Start Date

Jan 16, 2023

Study Type

INTERVENTIONAL

Conditions

Malignant Solid Neoplasm Hematopoietic and Lymphoid System Neoplasm

Summary

This clinical trial studies the effectiveness of a group curriculum in improving survivorship outcomes in adolescent and young adult (AYA) cancer survivors. Many AYA survivors typically do not feel prepared to re-enter "daily life" and would likely benefit from structured interventions to offer education and support in a timely manner as to prepare them for the challenges of life in survivorship. A 6-week group curriculum, designed to specifically meet the needs of AYA cancer survivors and facilitated by licensed social workers, may meet the unique needs of young adults who have survived a cancer diagnosis, and if so, the curriculum could be licensed and used across Mayo Clinic sites and potentially at other cancer centers nationwide.

Eligibility

Min Age: 18 YearsMax Age: 39 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying Counseling, a procedure called Discussion, and others for people with hematopoietic and lymphoid system neoplasm and malignant solid neoplasm. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years to 39 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.